MedPath

Evaluation of the WavSTAT Optical Biopsy System for the detection of early neoplasia in the Barrett oesophagus

Completed
Conditions
1) Barrett oesophagus
2) early oesophageal cancer
10017990
10017991
Registration Number
NL-OMON35892
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
129
Inclusion Criteria

- Age > 18 * 80 years;
- BO with a minimal circumferential length of 2 cm;
- BO without dysplasia (NDBO) and patients with BO referred for endoscopic work-up of HGIN or EC;
- Signed informed consent.

Exclusion Criteria

- Prior history of surgical or endoscopic treatment for oesophageal neoplasia;
- Presence of erosive oesophagitis (Los Angeles classification *B);
- Inability to obtain biopsies (e.g. due to anticoagulation, coagulation disorders, varices);
- Unable to provide signed informed consent.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Phase 1 will be used to develop a tissue recognition algorithm by correlating<br /><br>the measured fluorescence spectra to the histology of the corresponding tissue.<br /><br><br /><br>In phase 2 the WavSTAT optical biopsy will be validated and assessed for the<br /><br>following outcome parameters:<br /><br>1. sensitivity and specificity of WavSTAT for the detection of early Barrett<br /><br>neoplasia (HGIN/EC)<br /><br>2. additional value of WavSTAT to standard inspection with WLE, compared to<br /><br>inspection with WLE alone for the detection of early Barrett neoplasia<br /><br>(HGIN/EC).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>--</p><br>
© Copyright 2025. All Rights Reserved by MedPath